ALNYLAM PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of ALNY for the last quarter is 8.19 B MXN, and it's 9.69% higher compared to the previous quarter. The net income of Q1 24 is -1.09 B MXN.